| Literature DB >> 1089999 |
R Dobbs, H Sakurai, H Sasaki, G Faloona, I Valverde, D Baetens, L Orci, R Unger.
Abstract
Glucagon suppression by somatostatin reduces or abolishes hyperglycemia in dogs made insulin-deficient by somatostatin, alloxan, or total pancreatectomy. This suggests that the development of severe diabetic hyperglycemia requires the presence of glucagon, whether secreted by pancreatic or newly identified gastrointestinal A cells, as well as a lack of insulin. Glucagon suppression could improve therapeutic glucoregulation in diabetes.Entities:
Mesh:
Substances:
Year: 1975 PMID: 1089999 DOI: 10.1126/science.1089999
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728